How is it going with the Big Biopharma Earnings Week?…Update-5…a wild volatile week!
Update -5 ...5/6 A wild volatile week catalyzed by FED policy statements. We won't go into the debate over FED communications about rate hikes and just say that rising rates are a headwind for equities and curb speculation. With higher rates small cap growth has a higher bar of financial...
Risky Trading Days Lie Ahead, Can Earnings Support the Bulls? Update-4…. broad sell-off
4/26 The constellation of bad news is overwhelming the market: China lock-down, War in Ukraine, commodity prices and WTI up and a horrible tape. MSFT earnings should help us tomorrow but we are in a bear mindset. IBB down 3.86% to $119.39 a 52 week low and the XBI down 5.98% to $76.69 at...
Healthcare Stocks Lead the Way Up as the Market Fades…Update-2 rally day
Update-2 4/13 11;36 AM EDT....GSK buys Sierra Oncology (SRRA) for $1.9B https://www.bizjournals.com/sanjose/news/2022/04/13/glaxosmithkline-to-buy-sierra-oncology-for-19b.html?ana=yahoo XBI up 2.48% to $89 handle, ARKG up 2.35%. Large caps lag except REGN up. ABBV down over 5%! Green tape...
Good Entry Point for Biotech Stocks…Update-2. Healthcare Stocks up with XLV up 1.5%
Update-2 ...4/6 In volatile end of day trading with Tech stocks and the NASDAQ hit hard down 2.2%, healthcare stocks were winners with the XLV up 1.5%. Other sector winners were staples, energy, real estate and utilities. As one pundit put it, " the FED is intent on wealth destruction" to curb...
Biotech Funds and ETFs Continue to Lag…Update-2
4/1/22 Blah market but biotech and healthcare holds.Rally at last 30 min. Spec small caps on a green screen with both ARKG and XBI up. We are trading these stocks off a bottom. IWM up 0.9% to $207 level. Gene therapy stocks rallying: CRSP, EDIT, NTLA. Large caps strong:LLY, MRK, RHHBY, VRTX....